HAMBURG, Germany – U.K. firm Cellesce Ltd., based in Cardiff, Wales, will be collaborating during the next 12 months with the U.K. National Physical Laboratory to document the company's full range of colorectal cancer organoids, which could contribute to the development of an international imaging standard for organoid analysis.